Disease activity trajectories from childhood to adulthood in the population-based Nordic juvenile idiopathic arthritis cohort.
Journal Information
Full Title: RMD Open
Abbreviation: RMD Open
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"the unstable results observed when using more than four groups led us to proceed with four groups10 1136/rmdopen-2023-003759 supp3 supplementary data 10 1136/rmdopen-2023-003759 supp1 supplementary data following the approach of shoop-worrall et al we modelled the active joint count using a zero-inflated poisson distribution and phga and paga using normal distributions.; we smoothened the resulting curves using a low-pass filter to obtain better visualisations of the results10 1136/rmdopen-2023-003759 supp2 supplementary data 10 1136/rmdopen-2023-003759 supp4 supplementary data 10 1136/rmdopen-2023-003759 supp5 supplementary data we constructed a heat-map plot by hierarchical clustering to explore factors associated with the paga.; the proportion of active disease according to the acr criteria and a cjadas10>1 was slightly higher when excluding these patients compared with the four groups when all the patients were included ( table 3 ) 10 1136/rmdopen-2023-003759 supp6 supplementary data 10 1136/rmdopen-2023-003759 supp7 supplementary data table 4 cjadas10 and components at the three major visits for each trajectory group in the nordic juvenile idiopathic arthritis cohort n baseline n 8-year follow-up n 18-year follow-up p value* group 1 (mida-id) cjadas10 70 1 7 (0-3 9) 101 0 (0-0 1) 147 0 (0-0 5) <0 0001 0 40 active joint count 168 0 (0-1 0) 168 0 (0-0) 167 0 (0-0) <0 0001 0 03 paga 84 0 5 (0-1 5) 123 0 (0-0) 151 0 (0-0 5) <0 0001 0 01 phga 73 0 5 (0-1 0) 103 0 (0-0) 163 0 (0-0) <0 0001 0 45 group 2 (mida-mda) cjadas10 55 2 2 (1 5-4 5) 78 1 5 (0-3 7) 94 4 0 (1 5-8 5) 0 20 0 008 active joint count 104 0 (0-1 0) 101 0 (0-1 0) 104 0 (0-1 0) 0 36 0 50 paga 65 0 5 (0-1 5) 83 0 2 (0-1 2) 95 2 0 (0 5-4 5) 0 28 <0 0001 phga 57 0 9 (0 3-1 2) 81 0 5 (0-1 5) 101 1 0 (0-2 0) 0 29 <0 0001 group 3 (hda-mida) cjadas10 71 8 4 (5 0-12 7) 85 1 5 (0 2-4 0) 113 1 0 (0-3 0) <0 0001 0 33 active joint count 119 3 0 (2 0-5 0) 115 0 (0-1) 119 0 (0-0) <0 0001 0 0004 paga 76 2 2 (1 0-4 3) 89 0 4 (0-1 9) 115 0 5 (0-2 0) <0 0001 <0 0001 phga 72 2 4 (1 0-4 2) 86 0 3 (0-1 3) 116 0 (0-0 5) <0 0001 0 58 group 4 (hda-hda) cjadas10 26 13 8 (6 6-19 0) 27 7 8 (2 6-15 5) 35 10 0 (6 5-14 0) 0 08 0 46 active joint count 36 4 0 (2 5-10 0) 36 2 5 (0-6 0) 36 2 0 (0-3 5) 0 01 0 38 paga 26 2 8 (1 0-6 2) 28 1 9 (0 5-5 1) 35 4 0 (2 0-7 5) 0 99 <0 0001 phga 27 4 4 (2 0-5 1) 29 2 3 (0 8-5 0) 36 3 0 (1 0-4 5) 0 39 <0 0001 disease activity trajectory groups from baseline to 18-year follow-up."
"Competing interests: None declared."
"Funding: The work was supported by postdoctoral grants from the Helse Nord Research Program."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025